TERRACCIANO, Stefania
 Distribuzione geografica
Continente #
AS - Asia 7.592
NA - Nord America 3.690
EU - Europa 1.300
SA - Sud America 325
AF - Africa 35
Continente sconosciuto - Info sul continente non disponibili 3
OC - Oceania 3
Totale 12.948
Nazione #
HK - Hong Kong 6.046
US - Stati Uniti d'America 3.598
SG - Singapore 675
IT - Italia 381
CN - Cina 357
BR - Brasile 241
VN - Vietnam 191
RU - Federazione Russa 189
DE - Germania 185
UA - Ucraina 145
TR - Turchia 68
IE - Irlanda 64
FR - Francia 62
SE - Svezia 60
GB - Regno Unito 57
IN - India 55
FI - Finlandia 52
CA - Canada 50
KR - Corea 40
AR - Argentina 29
JP - Giappone 29
MX - Messico 27
BD - Bangladesh 23
NL - Olanda 20
PL - Polonia 19
ID - Indonesia 14
AT - Austria 13
CZ - Repubblica Ceca 13
ES - Italia 13
CO - Colombia 12
EC - Ecuador 12
IQ - Iraq 12
PH - Filippine 12
ZA - Sudafrica 12
PK - Pakistan 10
UZ - Uzbekistan 9
VE - Venezuela 9
AZ - Azerbaigian 8
CL - Cile 8
HU - Ungheria 6
MA - Marocco 6
SA - Arabia Saudita 6
DO - Repubblica Dominicana 5
MY - Malesia 5
OM - Oman 5
AE - Emirati Arabi Uniti 4
EG - Egitto 4
PE - Perù 4
RO - Romania 4
GT - Guatemala 3
JO - Giordania 3
KE - Kenya 3
KZ - Kazakistan 3
LT - Lituania 3
NP - Nepal 3
PY - Paraguay 3
RS - Serbia 3
UY - Uruguay 3
AU - Australia 2
BG - Bulgaria 2
BO - Bolivia 2
CH - Svizzera 2
DK - Danimarca 2
EU - Europa 2
IL - Israele 2
IR - Iran 2
PA - Panama 2
PS - Palestinian Territory 2
TJ - Tagikistan 2
TN - Tunisia 2
A2 - ???statistics.table.value.countryCode.A2??? 1
AL - Albania 1
AO - Angola 1
BE - Belgio 1
BH - Bahrain 1
CR - Costa Rica 1
ET - Etiopia 1
GA - Gabon 1
GF - Guiana Francese 1
GY - Guiana 1
HN - Honduras 1
JM - Giamaica 1
LA - Repubblica Popolare Democratica del Laos 1
LB - Libano 1
LC - Santa Lucia 1
ML - Mali 1
MN - Mongolia 1
MU - Mauritius 1
NG - Nigeria 1
NO - Norvegia 1
PR - Porto Rico 1
PT - Portogallo 1
PW - Palau 1
QA - Qatar 1
SK - Slovacchia (Repubblica Slovacca) 1
SN - Senegal 1
SY - Repubblica araba siriana 1
UG - Uganda 1
Totale 12.948
Città #
Hong Kong 6.032
Ann Arbor 579
Singapore 396
Dallas 325
Chandler 306
San Jose 284
Woodbridge 236
Ashburn 201
Jacksonville 173
Wilmington 170
Princeton 166
Houston 157
Salerno 99
The Dalles 79
Beijing 69
Council Bluffs 67
Dublin 62
Munich 59
Lauterbourg 55
Izmir 53
Ho Chi Minh City 52
Nanjing 46
Hanoi 44
Los Angeles 40
Naples 39
New York 38
Andover 35
Montreal 31
Orem 31
Boardman 30
Dearborn 29
Tokyo 29
Pellezzano 28
Moscow 24
Turku 24
Fisciano 23
São Paulo 22
Frankfurt am Main 20
Santa Clara 20
Stockholm 18
Brooklyn 17
Chengdu 17
Redwood City 17
Warsaw 17
Guangzhou 16
Fairfield 15
Nuremberg 15
Chennai 14
Columbus 14
Denver 14
Boston 13
Da Nang 12
Dong Ket 12
Jiaxing 12
London 12
Changsha 11
Hebei 11
Mexico City 11
Phoenix 11
Brno 10
Chicago 10
Johannesburg 10
Amsterdam 9
Atlanta 9
Belo Horizonte 9
Nanchang 9
Seattle 9
Shenyang 9
Düsseldorf 8
Hải Dương 8
Manchester 8
Mestre 8
New Delhi 8
Washington 8
Baku 7
Charlotte 7
Norwalk 7
Pune 7
San Francisco 7
Ankara 6
Curitiba 6
Dhaka 6
Milan 6
Ottawa 6
Tashkent 6
Baghdad 5
Biên Hòa 5
Caianello 5
Campinas 5
Chandigarh 5
Falls Church 5
Haiphong 5
Jakarta 5
Jinan 5
Medellín 5
Nürnberg 5
Szeged 5
Arzano 4
Des Moines 4
Guayaquil 4
Totale 10.727
Nome #
A Combinatorial Virtual Screening Approach Driving the Synthesis of 2,4-Thiazolidinedione-Based Molecules as New Dual mPGES-1/5-LO Inhibitors 1.126
Inhibition of Microsomal Prostaglandin E2 Synthase 1: focused design of new anti-inflammatory and anti-cancer drugs 941
Identification of 2-(thiophen-2-yl)acetic Acid-Based Lead Compound for mPGES-1 Inhibition 642
Protein Preparation Automatic Protocol for High-Throughput Inverse Virtual Screening: Accelerating the Target Identification by Computational Methods 612
40 th "A. Corbella" International Summer School on Organic Synthesis - ISOS 2015 594
Chemistry and biology of anti-inflammatory marine natural products: molecules interfering with cyclooxygenase, NF-κB and other unidentified targets 537
Design, Synthesis, and Biological Activity of Hydroxamic Tertiary Amines as Histone Deacetylase Inhibitors 532
In Silico Design, Chemical Synthesis, Biophysical and in Vitro Evaluation for the Identification of 1-Ethyl-1H-Pyrazolo[3,4-b]Pyridine-Based BRD9 Binders 521
Identification of Novel Bromodomain-Containing Protein 4 (BRD4) Binders through 3D Pharmacophore-Based Repositioning Screening Campaign 393
Identification of the 2-Benzoxazol-2-yl-phenol Scaffold as New Hit for JMJD3 Inhibition 362
9H-purine scaffold reveals induced-fit pocket plasticity of the BRD9 bromodomain 247
Cyclic Peptoids as Mycotoxin Mimics: An Exploration of Their Structural and Biological Properties 204
From Natural Compounds to Bioactive Molecules through NMR and In Silico Methodologies 200
Can Small Chemical Modifications of Natural Pan-inhibitors Modulate the Biological Selectivity? the Case of Curcumin Prenylated Derivatives Acting as HDAC or mPGES-1 Inhibitors 199
Targeting the Hsp90 C-terminal domain by the chemically accessible dihydropyrimidinone scaffold 188
Structural basis for the design and synthesis of selective HDAC inhibitors 187
Structural Insights for the Optimization of Dihydropyrimidin-2(1H)-one Based mPGES-1 Inhibitors 183
Exploration of the dihydropyrimidine scaffold for the development of new potential anti-inflammatory agents blocking prostaglandin E2 synthase-1 enzyme (mPGES-1) 181
Synthesis, Conformational Analysis, and Cytotoxicity of New Analogues of the Natural Cyclodepsipeptide Jaspamide 172
Identification of the key structural elements of a dihydropyrimidinone core driving toward more potent Hsp90 C-terminal inhibitors 168
Dimeric and trimeric triazole based molecules as a new class of Hsp90 molecular chaperone inhibitors 162
Identification of novel microsomal prostaglandin E2 synthase-1 (mPGES-1) lead inhibitors from Fragment Virtual Screening 162
Design and Synthesis of cyclopeptide analogues of the potent Histone deacetylase inhibitor FR235222 160
Identification of Lead Compounds as Inhibitors of STAT3: Design, Synthesis and Bioactivity 159
New dihydropyrimidin-2(1H)-one based Hsp90 C-terminal inhibitors 156
Correction: Identification of the key structural elements of a dihydropyrimidinone core driving toward more potent Hsp90 C-terminal inhibitors 156
Design,virtual Screening and Synthesis of Potential Microsomal Prostaglandine E2 Synthase-1 (mPGES-1)Inhibitors 154
Identification of 2,4,5-trisubstituted-2,4-dihydro-3H-1,2,4-triazol-3-one-based small molecules as selective BRD9 binders 142
Targeting Microsomal Prostaglanding E2 Synthase 1 for the Development of new potential Anti-Inflammatory Drugs 141
Discovery of new potent molecular entities able to inhibit mPGES-1 141
Effects of FR235222, a novel HDAC inhibitor, in proliferation and apoptosis of human leukaemia cell lines: role of annexin A1 139
Identification of Honokiol-Based Scaffold to Design Tankyrase 1/2 Inhibitors by In Silico and In Vitro Studies 138
Virtual screening of 3-(1H-1,2,3-triazol-1-yl)piperidine-2,6-dione-based compounds as new potential Cereblon modulators amenable for targeted protein degradation 134
Conformationally locked calixarene-based histone deacetylase inhibitors 132
Discovery and synthesis of the first selective BAG domain modulator of BAG3 as an attractive candidate for the development of a new class of chemotherapeutics 131
Chemistry and Biology of Anti-Inflammatory Marine Natural Products.Phospholipase A2 Inhibitors 130
Structure-Based Design of Microsomal Prostaglandin E2 Synthase-1 (mPGES-1) Inhibitors using a Virtual Fragment Growing Optimization Scheme 126
Total Synthesis, NMR Solution Structure, and Binding Model of the Potent Histone Deacetylase Inhibitor FR235222 122
Synthesis of new mono and bis amides projected as potential histone deacetylase (HDAC) inhibitors 122
Discovery of new molecular entities able to strongly interfere with Hsp90 C-terminal domain 122
2-Substituted 1,5-benzothiazepine-based HDAC inhibitors exert anticancer activities on human solid and acute myeloid leukemia cell lines 121
Hsp90 Activity Modulation by Plant Secondary Metabolites 120
Critical Surveys Covering the Year 2004:Total Synthesis of Natural Products 119
Molecular modeling studies toward the structural optimization of new cyclopeptide-based HDAC inhibitors modeled on the natural product FR235222 119
Chemoproteomics Reveals USP5 (Ubiquitin Carboxyl-Terminal Hydrolase 5) as Promising Target of the Marine Polyketide Gracilioether A 119
A multidisciplinary functional proteomics-aided strategy as a tool for the profiling of a novel cytotoxic thiadiazolopyrimidone 114
Identification by Inverse Virtual Screening of magnolol-based scaffold as new tankyrase-2 inhibitors 112
Synthetic and pharmacological studies on new simplified analogues of the potent actin-targeting Jaspamide 111
Glucopyranosylbianthrones from the Algerian Asphodelus tenuifolius: Structural Insights and Biological Evaluation on Melanoma Cancer Cells 107
Discovery of noscapine derivatives as potential β-tubulin inhibitors 103
Synthesis and biological activity of cyclotetrapeptide analogues of the natural HDAC inhibitor FR235222 102
Identification of the first-in-class dual inhibitor targeting BAG3 and HSP70 proteins to disrupt multiple chaperone pathways 101
Structural Refinement of 2,4-Thiazolidinedione Derivatives as New Anticancer Agents Able to Modulate the BAG3 Protein 98
Repositioning of Quinazolinedione-Based Compounds on Soluble Epoxide Hydrolase (sEH) through 3D Structure-Based Pharmacophore Model-Driven Investigation 91
Exploring the chemical space of functionalized [1,2,4]triazolo[4,3-a]quinoxaline-based compounds targeting the bromodomain of BRD9 91
Introducing structure-based three-dimensional pharmacophore models for accelerating the discovery of selective BRD9 binders 83
Synthesis, solution structure, and bioactivity of six new simplified analogues of the natural cyclodepsipeptide jaspamide 80
Targeting mPGES-1 by a Combinatorial Approach: Identification of the Aminobenzothiazole Scaffold to Suppress PGE2Levels 76
Identification of a New Promising BAG3 Modulator Featuring the Imidazopyridine Scaffold 65
Identification of 2,4-Dinitro-Biphenyl-Based Compounds as MAPEG Inhibitors 65
Identification of 2-Aminoacyl-1,3,4-thiadiazoles as Prostaglandin E2 and Leukotriene Biosynthesis Inhibitors 44
A Thiadiazolopyrimidinone-Based Molecule Targeting Annexin A6 Impairs Cell Motility and Epithelial-to-Mesenchymal Transition in Pancreatic Cancer Cells Lacking Annexin A1 17
Identification of a New Interesting BAG3 Modulator Able to Disrupt Cancer-Related Pathways 9
Disruption of c-Myc/Max heterodimerization induced by a novel anticancer agent endowed with 1,3-diphenylurea moiety: an in silico, chemoproteomics-based, and in vitro combined approach 7
The future of BRD9 inhibitors: a patent perspective (2019-present) 3
From Bench to Bedside: Translational Approaches to Cardiotoxicity in Breast Cancer, Lung Cancer, and Lymphoma Therapies 2
Carnosol modulates mPGES-1/PPAR-γ biological axis: from in silico to in vivo clinical imaging and investigations 1
Unveiling New Triazoloquinoxaline‐Based PROTACs Designed for the Selective Degradation of the ncBAF Chromatin Remodeling Subunit BRD9 1
Advancing Non-Small-Cell Lung Cancer Management Through Multi-Omics Integration: Insights from Genomics, Metabolomics, and Radiomics 1
Totale 13.100
Categoria #
all - tutte 31.421
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 31.421


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/202169 0 0 0 0 0 0 0 0 0 7 36 26
2021/2022315 4 0 0 5 9 8 10 11 49 38 45 136
2022/2023641 52 73 18 106 65 121 5 67 81 0 35 18
2023/2024288 20 42 20 12 38 54 13 22 6 8 10 43
2024/2025951 30 7 6 43 28 80 230 65 129 47 123 163
2025/20268.752 1.665 2.574 2.414 314 422 200 446 108 242 367 0 0
Totale 13.100